Alprostadil (Prostavasin®)
| Disease area studied | Abbreviated title | Phase | Study ID | Registry database | Study results | Plain language summary | Publication (if available) |
|---|---|---|---|---|---|---|---|
| Intermittent Claudication | Prostaglandin E1 in Outpatients With Intermittent Claudication | Phase 3 |
SP0580
Completed |
NCT01263925 |
LINK
|
Schellong SM, et al. Vasa;2017,46(5):403-405 | |
| Peripheral Arterial Occlusive Disease | Alprostadil in Peripheral Arterial Occlusive Disease (PAOD) Stage IV (ESPECIAL) | Phase 4 |
SP0777
Completed |
NCT00596752 2005-001970-29 |
LINK LINK |
Lawall, H. et al. Eur J Vasc Endovasc Surg;2017, 53(4):559-566 | |
| Macular Degeneration | Alprostadil in Maculopathy Study (AIMS) | Phase 3 |
SP0878
Terminated |
NCT00619229 2005-005686-11 |
LINK LINK |
"Augustin et al. Expert Opin Investig Drugs;2013;22;7;803-812. " |